Immuneering Corp Cl A
(IMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,388 | -14,308 | -53,472 | -38,388 | -25,793 |
| Depreciation Amortization | 194 | 26 | -253 | -35 | 81 |
| Accounts receivable | N/A | N/A | 12 | 12 | 12 |
| Accounts payable and accrued liabilities | 511 | 117 | -1,107 | -1,278 | -499 |
| Other Working Capital | -1,960 | -2,684 | -975 | -2,858 | -2,064 |
| Other Operating Activity | 2,626 | 1,357 | 6,826 | 5,353 | 3,096 |
| Operating Cash Flow | $-27,017 | $-15,491 | $-48,969 | $-37,193 | $-25,167 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 26,430 | 21,430 | 52,300 | 33,250 | 28,250 |
| PPE Investments | -70 | -38 | -343 | -172 | -115 |
| Purchase Of Investment | N/A | N/A | -44,661 | -28,915 | N/A |
| Investing Cash Flow | $26,360 | $21,393 | $7,297 | $4,164 | $28,135 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 980 | 980 | 28,645 | 28,637 | 28,616 |
| Other Financing Activity | 0 | 0 | -204 | -204 | -204 |
| Financing Cash Flow | $980 | $980 | $28,441 | $28,433 | $28,412 |
| Beginning Cash Position | 59,406 | 59,406 | 72,637 | 72,637 | 72,637 |
| End Cash Position | 59,729 | 66,287 | 59,406 | 68,040 | 104,018 |
| Net Cash Flow | $323 | $6,881 | $-13,231 | $-4,597 | $31,381 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,017 | -15,491 | -48,969 | -37,193 | -25,167 |
| Capital Expenditure | -70 | -38 | -343 | -172 | -115 |
| Free Cash Flow | -27,087 | -15,529 | -49,311 | -37,365 | -25,281 |